Zhang JZ, Xie X, Ma YT, Zheng YY, Yang YN, Li XM, Fu ZY, Dai CF, Zhang MM, Yin GT, Liu F, Chen BD, Gai MT (2016). Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis. Aging Dis, 7:36-44.
Miettinen HE, Korpela K, Hämäläinen L, Kontula K (1994). Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet, 94:189-192.
Baroni MG, Berni A, Romeo S, Arca M, Tesorio T, Sorropago G, Di Mario U, Galton DJ (2003). Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD. BMC Med Genet, 4:8.
Bhanushali AA, Das BR (2010). Influence of genetic variants in the apolipoprotein A5 and C3 gene on lipids, lipoproteins, and its association with coronary artery disease in Indians. J Community Genet, 1:139-148.
AshokKumar M, Subhashini NG, SaiBabu R, Ramesh A, Cherian KM, Emmanuel C (2010). Genetic variants on apolipoprotein gene cluster influence triglycerides with a risk of coronary artery disease among Indians. Mol Biol Rep, 37:521-527.
Masana L, Febrer G, Cavanna J, Baroni MG, Marz W, Hoffmann MM, Shine B, Galton DJ (2001). Common genetic variants that relate to disorders of lipid transport in Spanish subjects with premature coronary artery disease. Clin Sci, 100:183-190.
Wong WM, Hawe E, Li LK, Miller GJ, Nicaud V, Pennacchio LA, Humphries SE, Talmud PJ (2003). Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels. Circ Res, 92:969-975.
Olivieri O, Stranieri C, Bassi A, Zaia B, Girelli D, Pizzolo F, Trabetti E, Cheng S, Grow MA, Pignatti PF, Corrocher R (2002). ApoC-III gene polymorphisms and risk of coronary artery disease. J Lipid Res, 43:1450-1457.
Li XD, Sun ZH, Yang ZY, et al. (2006). APOAl/C3 gene cluster polymorphisms and risk of coronary artery disease. Chin J Gerontol, 26:745-747.
Han TL (2011). A5/C3 Gene cluser and the correlation to the patients with coronary artery disease in ShanDong coastal areas. Shandong University, 1-50.
Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, Pizzolo F, Sandri M, Malerba G, Pignatti PF, Corrocher R, Olivieri O (2007). The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis, 191:409-417.
Liu HK, Li FX, Zhang SZ, et al. (2005). Association of Sst I Polymorphism in Apolipoprotein C3 Gene withHypertriglyceridaemia in Coronary Atherosclerotic Heart Disease and Type II Diabetes Mellitus in ChinesePopulation. Yi Chuan Xue Bao, 32:11-18.
Liu HK (2005). Study on the association of single nucleotide polymorphisms in apolipoproteinAPOAl/C3/A4/A5 gene cluster with coronary heart disease and type II diabetes. Sichuan University, 1-116
Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, Cheng S, Lindpaintner K, Samani NJ (2004). Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J, 25:459-467.